Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma
Clinical trial NCT03639467 · UNKNOWN
Trial details
- NCT number
- NCT03639467
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2021-08-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.